From the 12/30/2020 release of VAERS data:

Found 12,171 cases where Vaccine is HEP and Serious and Submission Date on/before '2019-05-31'

This is page 6 out of 1,218

VAERS ID: 27055 (history)   Form: Version 1.0   Age: 45.0   Sex: Female   Location: Pennsylvania   Vaccinated: 1989-11-14 Onset: 1989-12-25    Days after vaccination: 41 Submitted: 0000-00-00 Entered: 1990-12-11 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. 0951R / 2 - / - Administered by: Other       Purchased by: Other Symptoms: Arthralgia, CSF test abnormal, Eye pain, Optic atrophy, Optic neuritis, Papilloedema, Photophobia, Visual disturbance SMQs:, Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Noninfectious meningitis (narrow), Glaucoma (broad), Optic nerve disorders (narrow), Demyelination (narrow), Lens disorders (broad), Corneal disorders (broad), Retinal disorders (broad), Ocular infections (broad), Arthritis (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? Yes ER or Doctor Visit? No Hospitalized? Yes, 6 days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: medical hx: chalazion Allergies: Diagnostic Lab Data: 08JAN90 CSF protein 52 mg/dl; CDC Split Type: WAES90020779 Write-up: Pt vaccinated with Recombivax HB developed eye pain, photophobia & loss of vision.

VAERS ID: 27116 (history)   Form: Version 1.0   Age: 36.0   Sex: Female   Location: Virginia   Vaccinated: 1990-09-10 Onset: 1990-09-27    Days after vaccination: 17 Submitted: 0000-00-00 Entered: 1990-12-18 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / - Administered by: Unknown       Purchased by: Unknown Symptoms: Asthenia, CSF test abnormal, Myelitis SMQs:, Guillain-Barre syndrome (broad), Immune-mediated/autoimmune disorders (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CSF SEP90 300 WBC/ML; CSF SEP90 Protein elevated CDC Split Type: WAES90111086 Write-up: Pt vaccinated with Recombivax HB developed progressive weakness in rt leg dx as transverse myelitis. Possibility of lumbosacral plexus inflammation was also considered. A cerebrospinal fluid tap was positive for 300WBC/ML.

VAERS ID: 27129 (history)   Form: Version 1.0   Age: 25.0   Sex: Female   Location: Kansas   Vaccinated: 1990-11-09 Onset: 1990-11-16    Days after vaccination: 7 Submitted: 0000-00-00 Entered: 1990-12-19 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (ENGERIX-B) / SMITHKLINE BEECHAM 587A4 / UNK - / - Administered by: Private       Purchased by: Unknown Symptoms: Haemolytic anaemia SMQs:, Haemolytic disorders (narrow), Systemic lupus erythematosus (broad), Immune-mediated/autoimmune disorders (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: EBU900596 Write-up: Pt vaccinated with Engerix-B developed hemolytic anemia. Treated w/seven pints of blood.

VAERS ID: 27130 (history)   Form: Version 1.0   Age: 44.0   Sex: Male   Location: Pennsylvania   Vaccinated: 1990-11-14 Onset: 1990-11-23    Days after vaccination: 9 Submitted: 0000-00-00 Entered: 1990-12-19 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. 46846 / UNK - / - Administered by: Private       Purchased by: Unknown Symptoms: Ecchymosis, Haematuria, Haemorrhage, Leukopenia, Petechiae, Red blood cell sedimentation rate increased, Thrombocytopenia SMQs:, Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 4 days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Pen VK Current Illness: Preexisting Conditions: Kidney calculus; Biopsy, breast; Mitral valve prolapse. Allergies: Diagnostic Lab Data: Monospot NOV90 - Positive; Hemoglobin 24NOV90 14.4; Hematocrit 40.5; Grnaulocytes 86.0; Lymphocytes 14.0; Prothrombin time 11.3; PTT 30 SEC; ESR 35.0 MM/HR; Urine RBC 4-10; Platelet count 7,000-342,000. CDC Split Type: WAES90111193 Write-up: Pt vaccinated with Recombivax HB c/o symptoms of a cold. Developed petechiae on his upper & lower extremities. PE revealed buccal ecchymoses. Lab revealed thrombocytopenia & positive monospot. Dx immune thrombocytopenia.

VAERS ID: 27134 (history)   Form: Version 1.0   Age: 37.0   Sex: Female   Location: Pennsylvania   Vaccinated: 1990-10-23 Onset: 1990-10-30    Days after vaccination: 7 Submitted: 0000-00-00 Entered: 1990-12-19 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. 0097S / UNK - / - Administered by: Private       Purchased by: Unknown Symptoms: Unevaluable event SMQs: Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? Yes ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: WAES90110366 Write-up: Pt vax w/ Recombivax HB reported that a pt rec''d 4th dose was dx a week later w/ diabetes mellitus. It was felt that DM is not related to hep vax. Pt was hosp for DM.

VAERS ID: 27157 (history)   Form: Version 1.0   Age:    Sex: Female   Location: Unknown   Vaccinated: 0000-00-00 Onset: 0000-00-00 Submitted: 0000-00-00 Entered: 1990-12-21 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / - Administered by: Unknown       Purchased by: Unknown Symptoms: Deafness SMQs:, Hearing impairment (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: WAES90120375 Write-up: Pt vaccinated with Recombivax HB developed a 100% hearing loss in rt ear and a 20% to 25% loss of hearing in the lt ear. Both losses were improved w/the use of a hearing aid.

VAERS ID: 27267 (history)   Form: Version 1.0   Age: 50.0   Sex: Female   Location: Florida   Vaccinated: 1990-04-16 Onset: 1990-04-16    Days after vaccination: 0 Submitted: 0000-00-00 Entered: 1990-12-31 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / - Administered by: Unknown       Purchased by: Unknown Symptoms: Asthma, Hypersensitivity, Oedema, Pneumonia, Urticaria SMQs:, Cardiac failure (broad), Anaphylactic reaction (narrow), Angioedema (narrow), Asthma/bronchospasm (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: WAES90120858 Write-up: Pt vaccinated with Heptavax-B developed urticaria, swelling all over her body, wheezing, bronchiolitis.

VAERS ID: 27348 (history)   Form: Version 1.0   Age: 22.0   Sex: Male   Location: Pennsylvania   Vaccinated: 1990-11-06 Onset: 1990-11-12    Days after vaccination: 6 Submitted: 0000-00-00 Entered: 1991-01-08 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / IM Administered by: Unknown       Purchased by: Unknown Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting SMQs:, Liver related investigations, signs and symptoms (narrow), Hepatitis, non-infectious (narrow), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? Yes Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: G-6-pd deficiency Allergies: Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl CDC Split Type: WAES90102791 Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.

VAERS ID: 27349 (history)   Form: Version 1.0   Age:    Sex: Female   Location: Montana   Vaccinated: 1990-11-19 Onset: 1990-12-03    Days after vaccination: 14 Submitted: 0000-00-00 Entered: 1991-01-08 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. 0359S / UNK - / - Administered by: Unknown       Purchased by: Unknown Symptoms: Diarrhoea, Infection SMQs:, Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow) Life Threatening? No Birth Defect? No Died? No Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: Stool Culture - Salmonellosis CDC Split Type: WAES90120890 Write-up: Pt vaccinated with Recombivax HB developed diarrhea was hospitalized. Stool culture revealed salmonellosis. Additional details have been requested.

VAERS ID: 27350 (history)   Form: Version 1.0   Age: 50.0   Sex: Female   Location: Florida   Vaccinated: 1990-04-16 Onset: 0000-00-00 Submitted: 0000-00-00 Entered: 1991-01-08 Vaccin­ation / Manu­facturer Lot / Dose Site / Route HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / - Administered by: Unknown       Purchased by: Unknown Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria SMQs:, Severe cutaneous adverse reactions (narrow), Anaphylactic reaction (narrow), Angioedema (narrow), Asthma/bronchospasm (narrow), Oropharyngeal allergic conditions (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad) Life Threatening? No Birth Defect? No Died? No Permanent Disability? Yes Recovered? No Office Visit? No ER Visit? Yes ER or Doctor Visit? No Hospitalized? Yes, ? days    Extended hospital stay? No Previous Vaccinations: ~ ()~~~In patient Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease. CDC Split Type: WAES90120585 Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.

New Search